Trial Profile

An open-label study to assess the efficacy and safety of LM011 in subjects diagnosed with Non-Alcoholic Steatohepatitis (NASH)

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 18 Apr 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs LM 011 (Primary)
Indications Non-alcoholic steatohepatitis
Focus Proof of concept; Therapeutic Use
Sponsors LifeMax Laboratories

Most Recent Events

04 Jun 2019 Status changed from not yet recruiting to recruiting.
24 Apr 2019 New trial record
23 Apr 2019 Recruitment completion is expected on 30 Aug 2019 according to Australian New Zealand Clinical Trials Registry.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com